Introduction
Fibronectin (FN) is a large, extracellular matrix (ECM) glycoprotein that functions as both plasma and ECM protein. It is composed of two subunits of about 230 and 250 kDa that are cross-linked by disulfide bonds. FN serves as an attachment factor for cell-matrix and cell-cell interactions in various biological processes such as adhesion, d i fferentiation, and migration (Rouslahti, 1981 (Rouslahti, , 1988 Hynes, 1990) . Many different FN polypeptides are generated from a single gene by alternative splicing (Borsi et al., 1987; Norton and Hynes,1987; Schwarzbauer et al., 1987; Zardi e t a l.,1987) . FN has several domains known to bind a variety of matrix proteins such as type I collagen and also it has a specific amino acid sequence RGD that is recognized by a transmembrane receptor, integrin expressed on many cells Rouslahti and Pierschbacher, 1987) . A variety of growth factors and cytokines are being evaluated as modulators of FN gene expression in many d i fferent cell types (Nernath et al.,1980; Senger et al. , 1983; Allen-Hoffmann and Mosher, 1987; Almendral et a l., 1988; Blatti et al., 1988; Bowlus et al., 1991; Dean e t al.,1988 , Dean et al ., 1989 . As we previously reported (Lee et al., 1996; Lee et al., 1997; Lee et al., 1998) , two intracellular signal pathways mediated by cAMP and protein kinase C (PKC) are involved in the regulation of FN gene expression. These findings led us to investigate whether protein phosphatase-dependent pathways may also be responsible for FN gene expression. Here, we reported that ascomycin and cyclosporin A, inhibitors of serine/threonine protein phosphatase type 2B (PP2B), stimulated FN gene expression in WI-38 human lung fibroblasts and its SV-40 transformed derivative, WI-38VA13, but not in MC3T3-E1 osteoblasts.
Materials and Methods

Materials
Minimal essential medium (MEM), α-MEM, and fetal bovine serum (FBS) were purchased from Gibco/BRL (Gaithersburg, MD, U.S.A. 
Cell cultures
A normal human lung fibroblast cell line WI-38, an SV-40 virus-transformed derivative of WI-38, WI-3 8 VA 1 3 , and a mouse calvarial osteoblastic cell line MC3T3-E1 were obtained from the American Type Culture Collection (Rockville, MD, U.S.A.). WI-38 and WI-3 8 VA13 were cultured in MEM supplemented with10% FBS. MC3T3-E1 was cultured in a-MEM supplemented with 10% FBS. Each medium used in this study was supplemented with 100 U/ml of penicillin, 100 mg/ml of streptomycin, and 0.1% nonessential amino acids (only for WI-3 8 VA 1 3 ) , and 1 mM pyruvic acid (only for WI-38VA13). Cells were incubated in a humidified atmosphere of 5% CO 2 a t 3 7 ˚ C .
Radioactive labeling and immunoprecipitation of FN
Confluent cells in 35-mm culture dishes were incubated with serum free media supplemented with 1% BSA and the indicated agents and then labeled for two hours with m e t h i o n i n e-free MEM containing 30 µCi/ml of [ 3 5 S ] methionine. Radiolabeled FN was immunoprecipitated as described previously (Lee et. al., 1996) . Excess (3 mg) of goat anti-human FN antibody was added to the combined samples of medium and cell layer extracts containing the same amounts of radioactive protein and then incubated at 4˚C for 1~2 h. The immune complexes were recovered by addition of 30 ml of protein ASepharose beads, and incubated with shaking for an additional1 hour. The adsorbed proteins on Sepharose beads were dissolved in a 30 ml of electrophoresis sample buffer heated at 100˚C for 4 min. Samples were analyzed by SDS-PAGE using a 6% gel, and subjected to fluorography.
Northern blot hybridizations
Total cellular RNA was isolated with acid guanidinium t h i o c y a n a t e-p h e n o l-chloroform as described previously (Chomczynski and Sacchi,1987) . Ten µg of total cellular RNA per sample were fractionated by electrophoresis on a 0.8% agarose gel containing 2.2 M formaldehyde, trans- ferred to a nylon membrane followed by hybridization and subsequent washing as described by Sambrook et a l. (1989) . A cDNA probe was labeled with [ 3 2 P ] d C T P using a random primed DNA labeling kit. The membrane was exposed to a X-ray film at -70˚C. The cDNA probes used for hybridization were FH1, human FN cDNA (Kornblihtt, et. al., 1983) and 18S ribosomal RNA cDNA.
Results and Discussion
In order to determine the effect of a PP2B inhibitor ascomycin on FN mRNA levels in normal and transformed lung fibroblasts, WI-38 and WI-3 8 VA13, respectively and in MC3T3-E1osteoblasts, cells were exposed to ascomycin ranging from 1 to1,000 ng/ml for 24 h and the steady state levels of FN mRNA were determined by Northern blot hybridization. Ascomycin increased FN mRNA levels in WI -38 and WI-38VA13 cells in a dosedependent manner but not in MC3T3-E1 cells (Figure 1 ). Cyclosporin A, another inhibitor of PP2B, also increased FN mRNA levels in WI-38 and WI-38VA13 cells but not in MC3T3-E1 cells (Figure 2) . A cDNA for 18S ribosomal RNA was used to correct the amount of RNA loaded. We also tested okadaic acid and calyculin A, protein phosphatase type 1 (PP1) and protein phosphatase type 2A (PP2A) inhibitors, resulting in marked stimulation of FN gene expression in MC3T3-E1 cells but not in WI-38 and WI-38VA13 cells (data not shown). These results suggest that the regulation of FN gene expression by protein dephosphorylation is different depending on cell types.
To study the time kinetics of mRNA levels, confluent WI-38 cells were treated with 1,000 ng/ml of cyclosporin A or 1,000 ng/ml of ascomycin for the indicated periods of time. Post-treatment levels of FN mRNA began to increase from 6 h up to 48 h with both agents. (Figure  3) . A protein synthesis inhibitor CHX was added 30 min before the addition of cyclosporin A. While CHX itself increased levels of FN mRNA in WI-38 cells, it blocked the cyclosporin A-induced increase of FN mRNA levels Figure 5 . Effect of phorbol myristate acetate (PMA) alone or in combination with ascomycin or cyclosporin A on fibronectin (FN) mRNA levels in WI-38. Cells were treated with PMA (10 ng/ml) in combination with cyclosporin A (1,000 ng/ml) or ascomycin (1,000 ng/ml) for 24 h. 18S,18S ribosomal RNA. We have reported that PMA increases FN synthesis and gene expression in WI-38 and WI-3 8 VA13 cells through the PKC-dependent pathway (Lee et al ., 1996) . We have also found that PMA induces FN gene expression in MC3T3 -E1 (data not shown). To investigate whether ascomycin and cyclosporin A effect the PMA-i n d u c e d FN synthesis or vice versa, WI-38 cells were treated with 10 ng/ml of PMA alone or in combination with ascomycin or cyclosporin A. A lower concentration (1 ng/ml) of ascomycin and cyclosporin A which merely stimulated FN gene expression was used. FN gene expression was stimulated by PMA alone but not by either ascomycin or cyclosporin A alone at a given concentration ( Figure 5 ). In addition, the PMA -induced stimulation was not enhanced by the combined treatment of PMA with either ascomycin or cyclosporin A ( Figure 5 ). These results suggest that the mechanism of PMA and ascomycin/cyclosporin A in the regulation of FN gene expression may share a common downstream pathway. This is the first report to show that PP2B is involved in the regulation of FN gene expression. Cyclosporin A and ascomycin are well-known immunosuppressants and their inhibitory action on calcineurin, a Ca 2+ /calmodulindependent PP2B, is mediated by making complex to their intracellular receptors, cyclophilin and FK506 binding protein, respectively (Fruman et al., 1994) . Cyclosporin A has been widely used for the prevention of a graft rejection (Liu et al., 1991) . However, one of the major concerns is its potential nephrotoxicity causing interstitial fibrosis (Myers, 1986) . Therefore, its effects on the transcription and synthesis of extracellular matrix proteins such as type I and IV collagen have been studied. Wolf e t a l. (1990) reported that cyclosporin A stimulated collagen synthesis and gene expression in kidney fibroblasts and tubular cells. Frizell et al. (1994) reported that another PP2B inhibitor FK506 also increased the expression of extracellular matrix genes. Here we reported that FN, one of the important extracellular matrix proteins, are also upregulated by cyclosporin A and ascomycin suggesting that the increased synthesis of FN by them may contribute to the tissue fibrosis which is one of major side effects of these immunosuppressant drugs. Although the precise mechanism of the action of cyclosporin A and ascomycin on FN gene expression are uncertain, the results of this study provide an insight for understanding the regulatory mechanisms of FN gene expression in response to various extracellular stimuli. Indeed, a recent study provided evidences that cyclosproin A induced transforming growth f a c t o r-β ( T G F -β) production which in turn enhanced tumor growth and the number of metastasis (Hojo et al., 1999) . Our results that cyclosporin A requires a new protein synthesis to induce FN synthesis suggest that the effect of cyclosporin A may act indirectly through TGF-β p r o d u c t i o n .
In addition, our results showed that the regulation of FN expression by protein phosphatase seems to be celltype specific since PP2B inhibitors such as cyclosporin A and ascomycin increased FN expression in fibroblasts but not in osteoblasts.
